Company News
BEXION RECEIVES $500,000 matching funds from State of Kentucky March
2009 NEW!
BEXION RECEIVES 2008 PHASE 1 SBIR GRANT 1R43CA136017-01A1: "SapC-DOPS
Nanovesicles for Treating Glioblastoma Multiforme" NEW!
BEXION to appear on Sky Radio in August (May 2008)
BEXION RECEIVES 2007 PHASE 1 SBIR GRANT R43CA130228-01: "A novel
biotherapeutic treatment for prostate cancer"
Series A closed on October 16, 2009 NEW!